معرفی
Sanjay Ramakrishnan is a Senior Lecturer at the UWA Medical School, affiliated with the Centre for Respiratory Health at The University of Western Australia. His primary roles include clinical and academic responsibilities in respiratory medicine, focusing on asthma, chronic obstructive pulmonary disease (COPD), and translational research. He is actively involved in clinical trials evaluating novel therapies and biomarkers for respiratory conditions.
Research Interests:
- Personalized management of asthma and COPD through biomarkers like eosinophils and exhaled nitric oxide (FeNO)
- Development of predictive risk models for asthma attacks (e.g., the ORACLE scale)
- Investigation of anti-inflammatory therapies (e.g., dupilumab, benralizumab) in COPD and asthma
- Evaluation of corticosteroid use in exacerbation management
Recent Research Trends:
His articles emphasize biomarker-driven approaches to stratify patients, assess treatment efficacy (e.g., in trials like ABRA and STOIC), and explore sustainable clinical practices. Key themes include reducing corticosteroid exposure, understanding type 2 inflammation mechanisms, and optimizing therapeutic outcomes in severe respiratory diseases.
Grants and Projects:
- Leading Phase III trials on tezepelumab and tozorakimab for COPD
- Investigating budesonide/glycopyrronium/formoterol combinations in COPD
- Co-leading the FINGERPRINT study on respiratory traits in preterm birth survivors
Labs/Teams: Collaborates within multidisciplinary teams at the Centre for Respiratory Health, focusing on translational research and clinical trials.
